WO2010109490A1 - A method for preparation of enantioselective composite membrane - Google Patents
A method for preparation of enantioselective composite membrane Download PDFInfo
- Publication number
- WO2010109490A1 WO2010109490A1 PCT/IN2010/000188 IN2010000188W WO2010109490A1 WO 2010109490 A1 WO2010109490 A1 WO 2010109490A1 IN 2010000188 W IN2010000188 W IN 2010000188W WO 2010109490 A1 WO2010109490 A1 WO 2010109490A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- enantioselective
- minutes
- amino acids
- mixture
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 168
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000002131 composite material Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000000926 separation method Methods 0.000 claims abstract description 49
- 150000001413 amino acids Chemical class 0.000 claims abstract description 44
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 230000008569 process Effects 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- 239000007864 aqueous solution Substances 0.000 claims description 30
- 238000000108 ultra-filtration Methods 0.000 claims description 27
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 24
- 239000004475 Arginine Substances 0.000 claims description 22
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 22
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- UWCPYKQBIPYOLX-UHFFFAOYSA-N benzene-1,3,5-tricarbonyl chloride Chemical compound ClC(=O)C1=CC(C(Cl)=O)=CC(C(Cl)=O)=C1 UWCPYKQBIPYOLX-UHFFFAOYSA-N 0.000 claims description 14
- 229920002492 poly(sulfone) Polymers 0.000 claims description 14
- 150000001412 amines Chemical class 0.000 claims description 13
- 239000004472 Lysine Substances 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 238000007598 dipping method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000012466 permeate Substances 0.000 claims description 6
- 238000001223 reverse osmosis Methods 0.000 claims description 6
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 229940086542 triethylamine Drugs 0.000 claims description 5
- 239000004952 Polyamide Substances 0.000 claims description 4
- 238000003821 enantio-separation Methods 0.000 claims description 4
- 150000004820 halides Chemical class 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 239000004695 Polyether sulfone Substances 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000614 phase inversion technique Methods 0.000 claims description 3
- 229920006393 polyether sulfone Polymers 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 2
- 239000008366 buffered solution Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000003618 dip coating Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 abstract description 11
- 235000001014 amino acid Nutrition 0.000 description 34
- 239000007788 liquid Substances 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 230000004907 flux Effects 0.000 description 6
- 238000001728 nano-filtration Methods 0.000 description 6
- 238000004483 ATR-FTIR spectroscopy Methods 0.000 description 5
- 230000005526 G1 to G0 transition Effects 0.000 description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 5
- 150000001266 acyl halides Chemical class 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012069 chiral reagent Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 229920005597 polymer membrane Polymers 0.000 description 4
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 3
- 238000012695 Interfacial polymerization Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000003949 imides Chemical group 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229960003433 thalidomide Drugs 0.000 description 3
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000012696 Interfacial polycondensation Methods 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001263 acyl chlorides Chemical class 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical class C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 235000008206 alpha-amino acids Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010406 interfacial reaction Methods 0.000 description 2
- 229940018564 m-phenylenediamine Drugs 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001197 polyacetylene Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- SGTNSNPWRIOYBX-MHZLTWQESA-N (S)-verapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-MHZLTWQESA-N 0.000 description 1
- BOSAWIQFTJIYIS-UHFFFAOYSA-N 1,1,1-trichloro-2,2,2-trifluoroethane Chemical compound FC(F)(F)C(Cl)(Cl)Cl BOSAWIQFTJIYIS-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000000777 acyl halide group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- -1 aromatic acyl halide Chemical class 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- SGTNSNPWRIOYBX-HHHXNRCGSA-N dexverapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-HHHXNRCGSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
- B01D69/125—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction
- B01D69/1251—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction by interfacial polymerisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/56—Polyamides, e.g. polyester-amides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/007—Separation by stereostructure, steric separation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
- B01D69/125—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/34—Preparation of optical isomers by separation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/06—Purification or separation of guanidine
Definitions
- the present invention relates to a method for the preparation of enantioselective composite membrane for separation of amino acids from their aqueous solutions and for optical resolution of racemic mixtures.
- the present invention particularly relates to a method for the preparation of enantioselective composite nanofiltration membrane useful for separation of optical isomers of amino acids.
- the enantioselective composite membranes of present invention are useful for separation of enantiomers from their mixture to obtain optical pure isomers.
- the enantioselective composite membranes of present invention can be used for optical resolution of racemic mixtures of amino acids and chiral compounds to obtain optically pure enantiomers in a pressure driven membrane process such as reverse osmosis, nanofiltration etc.
- Stereoisomers are those molecules which differ from each other only in the arrangement of their atoms within space. Stereo-isomers are generally classified as diastereomers or enantiomers; the latter embracing those which are mirror-images of each other and former being those which are not mirror images. Enantiomers (the mirror images), also known as optical isomers, have identical physical and chemical properties. Therefore a mixture of enantiomers as a rule can not be separated by ordinary separation methods, such as fractional distillation (boiling points being identical), as conventional crystallization unless the solvent is optically active (due to identical solubilities), as conventional chromatography unless adsorbent is optically active (because they are held equally onto ordinary adsorbent). The problem of separating enantiomers is further exacerbated by the fact that conventional synthetic techniques almost always produce a mixture of enantiomers. Thus separation of a mixture of enantiomers is a most challenging problem in analytical chemistry.
- enantiomers Separation of enantiomers is very important to organic compounds such as amino acids, drugs, pesticides, insecticides etc. because majority are optically active and exist as a pairs of optical isomers (enantiomers). Enantiomers of many chiral drugs show remarkably differences in their biological & pharmacological properties. One enantiomer may have drug activity, while the other may be inert or even harmful.
- (S)-verapamil is effective as a calcium channel blocker while (R)-verapamil produces cardiac side effects;
- 1-enantiomer of j3 -blocker propranolol is ⁇ 100 times more active than d-form;
- (R)(+)-enantiomer of thalidomide possesses the sleeping action and its (S)(-)-enantiomer possesses teratogenic action, the different in pharmacological action of thalidomide was found responsible for serious malformation in newborn babies of women who took drug during pregnancy, "Thalidomide Tragedy" in 1960 s etc. It is therefore "The United States Food and Drug Administration" has recently issued new regulations governing the marketing of chiral drugs. According to the new regulations, the pharmacological properties of each enantiomer of a chiral drug should be tested separately for therapeutic efficacy and safety,.
- Chromatographic techniques GC, HPLC, CE etc.
- Chromatographic methods require an appropriate chiral selector incorporated into the stationary phase (chiral ' stationary phase) or coated onto the surface of the column packing material (chiral coated stationary phases).
- Enantioselective Chiral columns having chiral stationary phases are costly and have finite working life. Therefore cost of separation is quite high.
- the contact time for the interfacial reaction is 10 seconds, and the reaction is substantially complete in 1 second.
- the resulting polysulfone/polyamide composite membrane is then air-dried.
- the membrane claims to exhibits good flux and salt rejection.
- various types of additives have been incorporated into the solutions used in the interfacial polycondensation reaction.
- the drawback of this membrane is that it is not enantioselective.
- the enantioselective polymer membranes described in prior arts as detailed above are asymmetric and dense membranes fabricated from chiral polymers such as polysaccharides and derivatives, poly ⁇ -amino acids, polyacetylene derivatives etc. Most of these polymers are crystalline in nature and do not have membrane forming ability. Therefore membranes made from such polymers are fragile hence difficult to handle. Poor mechanical properties restricted their use to dialysis mode of separation. In dialysis mode of separation the driving force is solute concentration gradient only, therefore these membranes exhibited very low rate of permeation.
- enantiomers separation membranes are prepared from non Chiral Polymers having grafted enantiomers recognizing molecules viz.; amino acids, proteins, oligo-peptides etc. These membranes have superior mechanical properties however during permeation recognition sites get saturated quickly being fixed in the polymer matrix therefore selectivity of such membranes decrease sharply with time.
- Composite membranes are typically prepared by coating a porous support membrane with an aqueous solution of polyfunctional amine, followed by coating with solution of a polyfunctional acyl halide in an organic solvent to prepare thin film discriminating layer of polyamide by interfacial polycondensation reaction between a polyfunctional amine and a polyfunctional acyl halide as described in various patents.
- the inventive steps involved in the present invention are i) discriminating layer of composite membrane has resulted by interfacial polymerization reaction of chiral amino acids and polyfunctional amine with polyfunctional acyl chloride, ( ⁇ ) the preparation of chiral enantioselective layer by interfacial method, requires very small amount of chiral compound and very large membrane having homo chiral environment can be fabricated, ( ⁇ i) the process minimizes the requirement of optically pure chiral reagent essential for the separation of racemic mixtures and (iv) the process bring chiral micro environment in the polymer membrane in the form of enantioselective thin layer supported on the ultrafiltration layer which results in higher flux and high selectivity.
- the main object of present invention is to provide a method for the fabrication of a self- supporting and perm-selective membrane for enantiomeric separation by pressure driven membrane processes such as reverse osmosis, nanofiltration, etc.
- Another object of present invention is to provide a composite membrane based on piperazine and trimesoyl chloride are non-enantioselective hence do not perform enantiomer separation.
- Another object of present invention is to provide high stability and retention of enantioselectivity with time.
- Still another object of the present invention is to provide a method for fabricating enantioselective composite nanofiltration membrane for separation of enantiomers of chiral molecules.
- Yet another object of the present invention to provide a membrane based method for optical resolution of a racemic mixture into optically pure isomers.
- Figure 1 shows ATR-FTIR spectra for chemical structure of the enantioselective layer of enantioselective composite membrane.
- the present invention provides a method for the preparation of enantioselective composite membrane useful for the separation of enantiomers from their mixture to obtain optically pure isomers, which comprise of:
- step (b) dip coating of ultrafiltration membrane as obtained from step (a) with a mixture comprising, 1-2% aqueous solution of amino acid or mixture of amino acids, polyfunctional amine and acid acceptor for a time period of 1 to 5 minutes, maintained the pH in the range of 10 to 13;
- step (c) removing the coated UF membrane from the mixture as obtained from step (b) and draining the extra solution from the UF membrane for 5 to 30 minutes;
- step (d) again dipping the coated membrane obtained from step (c) in 0.1-1% solution of triacyl halide in hexane for a time period of 1 to 5 minutes and draining the extra solution for 1 to 5 minutes;
- step (e) drying the membrane as obtained from step (d) for a time period of 1 to 4 hours;
- step (f) heating the membrane as obtained from step (e) for a time period of 1 to 15 minutes at a temperature in the range of 70 0 C to 100 0 C, followed by cooling and air drying for 1 to 2 hours;
- step (g) soaking the membrane as obtained from step (f) in deionized water upto 24 hours to obtain enantioselective composite membrane comprising an enantioselective layer on the ultrafilteration memberane and testing it for separation of amino acids from their aqueous solution.
- the enantioselective layer of composite " membrane used is enantioselective having thickness in the range of 400 to 1600A.
- amino acid or mixture of amino acids used is selected from the group consisting of at least two primary amino groups.
- the enantioselective layer of composite membrane used is of cross linked polyamide polymer having at least one chiral carbon atom.
- polyfunctional amine used is selected from metaphenylene diamine
- piperizine and acid acceptor used is selected from triethyl amine or NaOH.
- polyfiinctional triacyl halide used is trimesoyl chloride.
- the ultrafiltration membrane used is selected from the group consisting of polysulfone, poly ether sulfone, and polyvinylidienefiuoride having thickness in the range of 20-60 ⁇ m.
- the enantioselective composite membrane separates 50-70% arginine and 80-90% lysine from aqueous solution.
- ' a method for enantioseparation of racemic mixture of amino acids, using the enantioselective composite membrane, wherein the said process is carried out ' on a reverse osmosis membrane testing unit at trans membrane pressure ranging between 345 K Pa to 862 K Pa, using aqueous and/or buffered solution of amino acids in the range of 0.1 to 1% as feed at flow rate in the range of 300 to 800 ml per minute at 20- 30 0 C.
- Enantioselective thin film composite membranes of the present invention are prepared by coating a micro-porous support with basic amino acid (amino acids having two primary amino groups viz., arginine, lysine, etc.) or a mixture of basic amino acid, polyfunctional amine as meta phenylenediamine, piperazine, preferentially piperazine and an acid acceptor triethyl amine, NaOH preferably NaOH and then a polyfunctional acyl halide (having reactivity more than one) preferably trimesoyl chloride stepwise.
- basic amino acid amino acids having two primary amino groups viz., arginine, lysine, etc.
- polyfunctional amine as meta phenylenediamine
- piperazine preferentially piperazine and an acid acceptor triethyl amine
- NaOH preferably NaOH
- a polyfunctional acyl halide having reactivity more than one
- amino acid or a mixture of amino acid, polyfunctional amine and acid acceptor is preferably coated first followed by coating of polyfunctional acyl halide.
- the amino acid or mixture of amino acid and polyfunctional amine is coated from an aqueous solution and polyfunctional acyl halide is coated from an organic solution.
- First ultrafiltration membrane is fabricated from polymer materials such as Polysulfone, Polyethersulfone, Polyvinylidieneflouride, etc. preferably polysulfone by phase inversion technique.
- a solution of above-mentioned polymers of desired concentration 12 to 18 % w/w in aprotic solvents such as dimethylformamide, N, N dimethylacetamide etc (more precisely 18% w/w) is spreaded on non-woven polyester fabric (support) in uniform thickness, the support is then dipped in coagulation bath containing 2% aqueous solution of dimethylformamide after specified time varies from 10- 40 seconds.
- the membrane is washed with deionised water for several times.
- Ultrafiltration membrane so prepared is used for the preparation of enantioselective composite nanofiltration membranes of present invention, by preparing a thin enantioselective layer in-situ on the enantioselective layer of ultrafiltration membrane by interfacial polymerization technique by reacting 1-2% aqueous solution of a amino acid or a mixture of amino acid (arginine), polyfiinctional amine preferably piperazine (in ratio of 50-50 % arginine and piperazine) and an acid acceptor viz., triethyl amine, NaOH etc., preferably NaOH.
- the pH of aqueous solution is maintained at 10-13 preferably 12, with 0.1-1% solution of trimesoyl chloride in hexane.
- enantioselective layer on the enantioselective layer of ultrafiltration membrane it is first dip coated with aqueous solution of amino acid or a mixture of amino acid, a polyfiinctional amine preferably piperazine (in ratio of 50-50 % arginine and piperazine) and an acid acceptor viz., triethyl amine and NaOH for 1-5 minutes precisely 3 minutes.
- aqueous solution of amino acid or a mixture of amino acid, a polyfiinctional amine preferably piperazine (in ratio of 50-50 % arginine and piperazine) and an acid acceptor viz., triethyl amine and NaOH viz., triethyl amine and NaOH
- the UF membrane is then dip coated with 0.1- 1% solution of trimesoyl chloride in hexa ⁇ e precisely €.5%, for a period of about 1-5 minutes precisely 3 minutes.
- the resultant coated UF membrane is removed from trimesoyl chloride solution mixture and membrane is drained off for 1-5 minutes precisely for 5 minutes to remove excess solution of trimesoyl chloride.
- the membrane is then air dried for 1-4 hours precisely 4 hours, then cured by heating at a temperature of 70-100 0 C precisely at 90 0 C for 1-15 minutes, precisely for 10 minutes.
- the resultant membrane is then cooled and dried in air for two hours and then soaked in water upto 24 hours to obtain the desired enantio selective composite membrane.
- FIGURE 1 The enantioselective composite membrane was characterized by ATR-FTIR spectrophotometer for chemical structure of its the enantioselective layer.
- ATR-FTIR spectra of polysulfone membrane before coating and after coating were recorded on a Perkin-Elmer spectrometer (Perkin-Elmer Spectrum GX, ATR-FTIR) using a Germanium crystal at a nominal incident angle of 45° at speed of 100 scans at a resolution of 2 cm "1 .
- ATR-FTIR spectra of polysulfone membrane (A) and after coating (B) it with poly (piperazinecoarginine trimesamide) film in-situ are given below.
- the peaks at 1487-90 cm '1 , and 1584 cm “1 are characteristics of polysulfone support.
- the peak at 1667 cm “1 in the spectra of coated membrane is indicative of amide formation.
- Characteristic absorption at 1731 cm “1 (imide ring C O), 1369 cm “1 (C-N-C, imide in the plane), and 747 cm “1 (C-N-C, out-of-plane bending, imide).
- the membranes were tested for separation of amino acids preferably arginine, lysine, alanine etc from their aqueous and buffer solution and enantioseparation of racemic mixture of amino acids on reverse osmosis membrane testing unit at trans-membrane pressure in the range of 345 -862 K Pa, precisely at 552 KPa, using 0.1-1%, aqueous solution and buffer solution of amino acids as feed at flow rate varies from 300-800 ml per minute precisely 500 ml per minute at 25 0 C temperature.
- the concentration of amino acids in permeate was determined by UV-Vis spectrophotomer at 290 nm and the ratio of d and 1-enantiomers in permeate to determine the enantiomeric excess(ee%) was estimated on HPLC fitted with PDA detector, by using Chiral column Chrompack(+) supplied by Diacel Chemical Industries, USA.
- Enantiomers are chiral molecules having identical molecular formula and chemical structure, but differ only in their spatial orientation. The difference in spatial orientation has many implications as biological and pharmaceutical activities of many chiral compounds are entirely different. Therefore use of such compounds in optically pure form is imminent.
- the separation of enantiomers presents a difficult problem. Many techniques are known in the art for separation of enantiomers based on different techniques. All enantioseparation techniques are based on the chiral micro environment in the vicinity of the racemic mixture for identifying the paired enantiomers.
- the presence of homo-chiral environment is essential to discriminate paired enantiomers.
- the novelty of the membrane of the present invention is to bring chiral micro environment in the polymer membrane in the form of the enantioselective layer thin layer supported on the ultrafiltration layer which results higher flux and higher selectivity.
- the composite membranes of present invention have enantioselective layer chiral discriminating layer that has been prepared in-situ on the ultrfiltration membrane.
- the enantioselective layer discriminating layer has resulted by interfacial polymerization reaction of chiral amino acids and polyfunctional amine with polyfunctional acyl chloride.
- the Preparation of chiral enantioselective layer by interfacial method requires very small amount of chiral compound and very large membrane having homo-chiral environment can be fabricated. Thus minimizes the requirement of optically pure chiral reagent essential for separation of racemic mixtures.
- Enantioselective composite membrane was prepared by impregnating polysulfone UF membrane in 1% aqueous solution of arginine and Piprazine (50:50) for 3 minutes, pH of solution was maintained to 12 by adding IN NaOH, draining extra solution for 15 minutes and then dipping membrane in 0.5% solution of trimesoyl chloride in hexane for 2 minutes, extra solution was drained for 2 minutes then drying the membrane for 4 hours in air. The membrane was heat cured for 5 minutes at 90 0 C temperature, cooled to 25 0 C temperature, air dried for 2 hours, then soaked in deionized water upto 24 hours.
- the membrane was tested for separation and enantioselctivity for arginine at standard conditions; 0.1% aqueous solution of racemic arginine as feed at flow rate 500ml per minute at 552 KPa. Membrane exhibited permeation rate 636 l/m 2 /day and 75% rejection for arginine. Enantioselcetivity for d-arginine was observed 65% .
- Enantioselective composite membrane was prepared by impregnating polysulfone UF membrane in 1% aqueous solution of arginine and Piprazine (50:50) for 3 minutes, pH of solution was maintained to 12 by adding IN NaOH, draining extra solution for 15 minutes and then dipping membrane in 1% solution of trimesoyl chloride in hexane for 2 minutes, extra solution was drained for 5 minutes then drying the membrane for 4 hours in air. The membrane was heat cured for 5 minutes at 90 0 C temperature, cooled to 25 0 C temperature; air dried for 2 hours, then soaked in deionized water upto 24 hours.
- the membrane was tested for separation and enantioselctivity for arginine at standard conditions; using 0.1% aqueous solution of racemic arginine as feed at flow rate 500ml per minute at 552 KPa. Membrane exhibited permeation rate 734 1/nr/day after 6 hours and 66% rejection for arginine. Enantioselectivity for d arginine was 50%.
- Enantioselective composite membrane was prepared by impregnating polysulfone UF membrane in 1% aqueous solution of Piprazine for 3 minutes, pH of solution was maintained to 12 by adding IN NaOH, draining extra solution for 15 minutes and then dipping membrane in 0.5% solution of trimesoyl chloride in hexane for 2 minutes, extra solution was drained for 5 minutes then drying the membrane for 4 hours in air.
- the membrane was heat cured for 5 minutes at 90 0 C temperature, cooled to 25 0 C temperature, air dried for 2 hours, then soaked in deionized water upto 24 hours.
- the membrane was tested at standard conditions using 0.1% aqueous solution, of racemic arginine as feed with flow rate 500ml per minute at 552 KPa. Membrane exhibited, permeation rate 1125 1/mVday and 60% rejection for arginine. Membrane did not show , enantioselectivity for d arginine.
- Enantioselective composite membrane was prepared by impregnating polysulfone UF membrane in 1% aqueous solution of arginine at 12 pH by adding IN NaOH for 3 minutes, draining extra solution for 15 minutes and then dipping membrane in 0.5% solution of trimesoyl chloride in hexane for 2 minutes, extra solution was drained for 2 minutes then drying the membrane for 4 hours in air.
- the membrane was heat cured for 5 minutes at 90 0 C temperature, cooled to 25 0 C temperature, air dried for 2 hours, then soaked in deionized water upto 24 hours.
- the membrane was tested at standard conditions using 0.1% aqueous solution of racemic arginine as feed with flow rate 500ml per minute at 552 KPa.
- Membrane exhibited permeation rate 1125 1/mVday and 48% rejection for arginine and Membrane exhibited enantioselectivity for d-arginine 50%.
- Enantioselective composite membrane was prepared by impregnating polysulfone UF membrane in 1% aqueous solution of lysine and Piprazine (50:50) at 12 pH for 5 minutes, draining extra solution for 15 minutes and then dipping membrane in 0.5% solution of trimesoyl chloride in hexane for 5 minutes, extra solution was drained for 5 minutes then drying the membrane for 4 hours in air.
- the membrane was heat cured for 5 minutes at 90 0 C temperature, cooled to 25 0 C temperature; air dried for 2 hours and then soaked in deionized water upto 24 hours.
- the membrane was tested at standard conditions using 0.1% aqueous solution of racemic lysine as feed with flow rate 500ml per minute at 552 KPa.
- Membrane exhibited permeation rate 587.19 1/mVday and 83% rejection for lysine.
- Membrane exhibited enantioselectivity for d lysine 90%.
- the membrane exhibited permeation rate 293.5 ⁇ 1 / m 2 /day, 46% rejection for lysine and enantioselectivity for d-lysine was 60%.
- the membrane exhibited volumetric flux 342.30 1/mVday and lysine rejection 72%.
- the enantioselectivity for d-alanine was 56%.
- the enantioselective polymer membranes described in prior art are asymmetric and dense membranes fabricated from chiral polymers such as polysaccharides and derivatives, poly ⁇ -amino acids, polyacetylene derivatives etc.
- Most membranes are fragile have poor mechanical properties thus posses difficulties to handle membrane, as a result their use is restricted to dialysis mode of separation. In dialysis mode of separation the driving force is solute concentration across the membrane therefore membranes exhibit very low rate of permeation.
- Membranes having superior mechanical properties exhibit enantioselectivity in the beginning but selectivity decrease sharply with time due to saturation of recognition sites.
- the composite membranes of the present invention can be used to perform enantiomers separation at commercial scale.
- the composite membranes of the present invention exhibits permeation flux of 6-24 gallon/feetVday depending upon trans-membrane pressure.
- the composite membranes of present invention can be used in pressure driven separation process at pressure varies from 345 to 862 K Pa.
- the higher trans-membrane pressure result higher flux thereby higher productivity.
- the composite membranes of present invention are stable and mechanically superior therefore it is to handle and convert into modular form.
- the enantiomers separation methods described in prior arts are often batch processes even if continuous, could not be adapted for a large scale continuous separation.
- the enantiomers separation process using membranes of present invention would be a continuous process and can be adapted for a large scale continuous separation.
- the enantiomers separation process of present invention would exhibit high rate of transport and the degree of separation in a reasonable time period to make feasible for large scale amino acids separation from their aqueous solution and mixture.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020117025333A KR101573968B1 (en) | 2009-03-27 | 2010-03-25 | A method for preparation of enantioselective composite membrane |
JP2012501507A JP5619867B2 (en) | 2009-03-27 | 2010-03-25 | Method for producing enantioselective composite membrane |
CN201080022405.5A CN102438734B (en) | 2009-03-27 | 2010-03-25 | A method for preparation of enantioselective composite membrane |
DE112010001374T DE112010001374T5 (en) | 2009-03-27 | 2010-03-25 | Process for the preparation of an enantioselective composite membrane |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN629/DEL/2009 | 2009-03-27 | ||
IN629DE2009 | 2009-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010109490A1 true WO2010109490A1 (en) | 2010-09-30 |
Family
ID=42237004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2010/000188 WO2010109490A1 (en) | 2009-03-27 | 2010-03-25 | A method for preparation of enantioselective composite membrane |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5619867B2 (en) |
KR (1) | KR101573968B1 (en) |
CN (1) | CN102438734B (en) |
DE (1) | DE112010001374T5 (en) |
WO (1) | WO2010109490A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102179185A (en) * | 2011-03-29 | 2011-09-14 | 北京化工大学 | Method for preparing chiral separation solid film |
WO2013118148A1 (en) * | 2012-02-06 | 2013-08-15 | Council Of Scientific & Industrial Research | "l-enantiomers selective membrane for optical resolution of alpha-amino acids and process for the preparation thereof" |
CN103357279A (en) * | 2013-07-30 | 2013-10-23 | 云南师范大学 | Teicoplanin chiral conposite membrane and its application in separation of D,L-p-hydroxyphenylglycine racemates |
EP3329986A4 (en) * | 2015-07-31 | 2019-04-03 | Toray Industries, Inc. | Separation membrane, separation membrane element, water purifier and method for producing separation membrane |
CZ308513B6 (en) * | 2019-03-24 | 2020-10-14 | Ústav Chemických Procesů Av Čr, V. V. I. | Composite chiral membrane, preparation method and methods of enrichment of mixtures of enantiomers |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104437110B (en) | 2014-12-15 | 2016-09-28 | 湖南澳维环保科技有限公司 | A kind of big flux polyamide composite film |
CN110339724B (en) * | 2019-06-26 | 2021-08-03 | 四川大学 | Composite polyamide membrane with salt concentration responsiveness and preparation method and application thereof |
KR102646731B1 (en) * | 2021-06-24 | 2024-03-12 | 이화여자대학교 산학협력단 | Method for preparing chiral nanostructures using block copolymers |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2233248A (en) * | 1989-06-07 | 1991-01-09 | Aligena Ag | Enantiomer enrichment by membrane processes |
US5498335A (en) * | 1992-04-14 | 1996-03-12 | Millipore Corporation | Process for forming porous polmyeric product from a nonporous polymeric composition and product |
US6270640B1 (en) * | 1998-04-29 | 2001-08-07 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Polymerized oligopeptide-surfactant chiral micelles |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4277344A (en) | 1979-02-22 | 1981-07-07 | Filmtec Corporation | Interfacially synthesized reverse osmosis membrane |
JPS60193930A (en) * | 1984-03-13 | 1985-10-02 | Daicel Chem Ind Ltd | Separation agent |
JPH0651789B2 (en) * | 1985-03-20 | 1994-07-06 | 正木 長谷川 | Optically active polyamide |
JP2547216B2 (en) * | 1987-07-08 | 1996-10-23 | ダイセル化学工業株式会社 | Separation agent |
US5080795A (en) | 1990-05-23 | 1992-01-14 | Research Corporation Technologies, Inc. | Supported chiral liquid membrane for the separation of enantiomers |
JP2898723B2 (en) * | 1990-08-31 | 1999-06-02 | ダイセル化学工業株式会社 | Optical splitting separation membrane |
US5205934A (en) | 1991-08-30 | 1993-04-27 | Membrane Products Kiryat Weitzman Ltd. | Silicone-derived solvent stable membranes |
JP3170724B2 (en) * | 1992-03-11 | 2001-05-28 | 味の素株式会社 | Detergent composition |
JPH115753A (en) * | 1997-06-17 | 1999-01-12 | Nippon Kayaku Co Ltd | Agent for optical resolution and optical resolution using the same |
BE1012622A3 (en) | 1999-04-21 | 2001-01-09 | Solvay | PROCESS TO SEPARATE AND REACTIVE ENANTIOMERS enantiopure. |
CA2391811C (en) | 1999-09-17 | 2009-12-22 | Borje Sellergren | New molecularly imprinted polymers grafted on solid supports |
US6485650B1 (en) | 2000-08-28 | 2002-11-26 | Facilichem, Inc. | Liquid membrane separation of enantiomers |
CN100342958C (en) * | 2005-11-02 | 2007-10-17 | 华东理工大学 | Composite fiber membrane with chiral molecular imprint and its prepn and application |
JP2007253109A (en) * | 2006-03-24 | 2007-10-04 | Nitto Denko Corp | Method for manufacturing dry composite semipermeable membrane |
JP2009091535A (en) * | 2007-10-10 | 2009-04-30 | Plascoat Kk | Optically active polymer |
-
2010
- 2010-03-25 JP JP2012501507A patent/JP5619867B2/en not_active Expired - Fee Related
- 2010-03-25 KR KR1020117025333A patent/KR101573968B1/en not_active IP Right Cessation
- 2010-03-25 DE DE112010001374T patent/DE112010001374T5/en not_active Ceased
- 2010-03-25 WO PCT/IN2010/000188 patent/WO2010109490A1/en active Application Filing
- 2010-03-25 CN CN201080022405.5A patent/CN102438734B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2233248A (en) * | 1989-06-07 | 1991-01-09 | Aligena Ag | Enantiomer enrichment by membrane processes |
US5498335A (en) * | 1992-04-14 | 1996-03-12 | Millipore Corporation | Process for forming porous polmyeric product from a nonporous polymeric composition and product |
US6270640B1 (en) * | 1998-04-29 | 2001-08-07 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Polymerized oligopeptide-surfactant chiral micelles |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102179185A (en) * | 2011-03-29 | 2011-09-14 | 北京化工大学 | Method for preparing chiral separation solid film |
WO2013118148A1 (en) * | 2012-02-06 | 2013-08-15 | Council Of Scientific & Industrial Research | "l-enantiomers selective membrane for optical resolution of alpha-amino acids and process for the preparation thereof" |
CN103357279A (en) * | 2013-07-30 | 2013-10-23 | 云南师范大学 | Teicoplanin chiral conposite membrane and its application in separation of D,L-p-hydroxyphenylglycine racemates |
CN103357279B (en) * | 2013-07-30 | 2015-09-30 | 云南师范大学 | Teicoplanin chiral composite membrane and the application in D, L-D-pHPG racemate resolution thereof |
EP3329986A4 (en) * | 2015-07-31 | 2019-04-03 | Toray Industries, Inc. | Separation membrane, separation membrane element, water purifier and method for producing separation membrane |
US11167249B2 (en) | 2015-07-31 | 2021-11-09 | Toray Industries, Inc. | Separation membrane, separation membrane element, water purifier, and method for producing separation membrane |
CZ308513B6 (en) * | 2019-03-24 | 2020-10-14 | Ústav Chemických Procesů Av Čr, V. V. I. | Composite chiral membrane, preparation method and methods of enrichment of mixtures of enantiomers |
Also Published As
Publication number | Publication date |
---|---|
CN102438734B (en) | 2014-05-28 |
CN102438734A (en) | 2012-05-02 |
JP2012521869A (en) | 2012-09-20 |
DE112010001374T5 (en) | 2012-07-26 |
KR20120012801A (en) | 2012-02-10 |
JP5619867B2 (en) | 2014-11-05 |
KR101573968B1 (en) | 2015-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010109490A1 (en) | A method for preparation of enantioselective composite membrane | |
JP6643624B2 (en) | Solvent resistant polyamide nanofiltration membrane | |
EP2859938B1 (en) | Highly permeable carbodiimide comprising reverse osmosis membrane and method for preparing same | |
Ingole et al. | Enantioselective permeation of α-amino acid isomers through polymer membrane containing chiral metal–Schiff base complexes | |
Chen et al. | Membrane-based technologies in the pharmaceutical industry and continuous production of polymer-coated crystals/particles | |
KR101114668B1 (en) | Manufacturing method for polyamide-based reverse osmosis membrane and polyamide-based reverse osmosis membrane manufactured thereby | |
WO2018049013A1 (en) | Membranes with alternative selective layers | |
Ingole et al. | Methods for separation of organic and pharmaceutical compounds by different polymer materials | |
AU2017208205A1 (en) | Polysulfonamide membrane by interfacial polymerisation | |
JP6196712B2 (en) | Polymer matrix formed from monomers containing protected amine groups | |
Son et al. | Chiral separation of d, l‐serine racemate using a molecularly imprinted polymer composite membrane | |
US20150005530A1 (en) | L-enantiomers selective membrane for optical resolution of alpha-amino acids and process for the preparation thereof | |
Singh et al. | Optical resolution of α-amino acids by reverse osmosis using enantioselective polymer membrane containing chiral metal-schiff base complex | |
Ciriani et al. | Semi-continuous and continuous processes for enantiomeric separation | |
JP2009034030A5 (en) | ||
KR20140005489A (en) | High flux reverse osmosis membrane comprising xanthene compound and manufacturing method thereof | |
KR100817450B1 (en) | Molecualr imprinted separation membrane for preparing optically pure compounds and method of preparing the same | |
KR20170130308A (en) | Method for manufacturing water-treatment membrane, water-treatment membrane manufactured by thereof, and water treatment module comprising membrane | |
KR20180086037A (en) | Composition for preparing reverse osmosis membrane, method for preparing reverse osmosis membrane using the same, reverse osmosis membrane and water treatment module | |
KR20060065810A (en) | Producing method of polyamide reverse osmosis membrane having high salt rejection property | |
EP1230971B1 (en) | Composite polyamide reverse osmosis membrane and method for producing the same | |
Tian et al. | Chiral Separation of D, L-Mandelic Acid Using An Enantioselective Membrane Formed by Polycondensation of [beta]-Cyclodextrin with 1, 6-Diisocyanatohexane on A Polysulfone Membrane | |
KR102212132B1 (en) | Separation membrane, composition for active layer of separation membrane, and method for separation membrane | |
Hatanaka et al. | Polyurea bearing L-lysinyl residue as a chiral building block and its application to optical resolution | |
Ingole et al. | Synthesis of solid enantioselective macromer of trimesic acid for the enantiomeric separation of chiral alcohols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080022405.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10719790 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012501507 Country of ref document: JP Ref document number: 112010001374 Country of ref document: DE Ref document number: 1120100013748 Country of ref document: DE |
|
ENP | Entry into the national phase |
Ref document number: 20117025333 Country of ref document: KR Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10719790 Country of ref document: EP Kind code of ref document: A1 |